When p-fluorophenylalanine (FPA) was added to influenza virus RI/5+-infected cells 4 hr after infection, virus-specific proteins were synthesized but infectious progeny virus was not produced. In these cells, synthesis of viral RNA was strongly inhibited and nucleoprotein (NP) antigen was found predominantly in the nucleus in contrast to untreated cells in which NP antigen was distributed throughout the whole cell. The intracellular location and migration of NP were examined by isotope labeling followed by fractionation of infected cells. In untreated cells, a large portion of the NP was present in the cytoplasm and most of it was detected in the form of ribonucleoprotein (RNP). In contrast, in FPAtreated cells little viral RNP was detectable and NP was present predominantly in the nucleus in a nonassembled, soluble form. When FPA was removed from the culture, synthesis of viral RNA was soon restored and a large amount of viral RNP appeared in the cytoplasm; this was followed by the production of infectious virus. The results of the experiments suggest that the NP synthesized in the presence of FPA is not assembled into viral RNP because of the lack of available RNA, and such NP migrates readily into the nucleus and accumulates there.Influenza ribonucleoprotein (RNP) consists of multiple molecules of nucleoprotein (NP) and one segment of virion RNA (vRNA) or cRNA complementary to vRNA (2, 15). Intracellular development of RNP has been studied extensively by immunofluorescence (1,4,5,10,11,16,21). The NP antigen appears first in the nucleus and later becomes distributed throughout the cytoplasm. However, under certain conditions such as an abortive infection in L cells (4), virus growth in the presence of p-fluorophenylalanine (FPA) (21) or infection with von Magnus-type incomplete virus (16), NP antigen remains in the nucleus throughout the infection. The mechanism by which NP antigen remains in the nucleus is not yet clear,